In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
This podcast focuses on how emerging tools can enable better collaboration and engagement with both internal and external stakeholders.
In conversation with John Pracyk, MD, PhD, MBA, Medical Affairs leaders from Johnson & Johnson describe best practices to prepare our next generation of Chief Medical Officers.
This podcast focuses on applications of Real World Evidence including FDA criteria for accepting RWE, types of data, RWE study designs and the Totality of Evidence approach.
A guide for Medical Communications cross-functional collaboration to develop an Integrated Medical Communications Strategy and Plan (iMC S/P) which is the roadmap for how a Medical Affairs team communicates its product vision and value proposition to internal and external stakeholders.
This podcast focuses on how to use integrated HCP data and network analytics to get faster, better insights from disease communities.
In this webinar, our panelists share their experience, challenges, and practical solutions regarding driving insights into action.
In this installment of the Leadership Perspectives series, we speak with some of the top Medical Affairs leaders from Johnson & Johnson as they think about the rapid new ascension of Medical Affairs into a fully integrated strategic business partner.
In this webinar, an MSL, a Medical Field Excellence Leader, and a Solution Provider discuss an aligned partnership to supercharge scientific exchange.
There is growing interest globally in using real-world data (RWD) and real-world evidence (RWE) for applications including regulatory decisions, health technology assessment (HTA), pharmacovigilance and more. However, Asia currently lacks a framework to effectively collect and utilize a broad range of RWD/RWE.